Literature DB >> 29376521

Tumour budding in colorectal cancer: molecular rationale for clinical translation.

Inti Zlobec1, Alessandro Lugli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29376521     DOI： 10.1038/nrc.2018.1

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  10 in total

1.  DNA profiling of tumor buds in colorectal cancer indicates that they have the same mutation profile as the tumor from which they derive.

Authors:  Irene Centeno; Aino Paasinen Sohns; Miriam Flury; José A Galván; Stefan Zahnd; Viktor H Koelzer; Lena Sokol; Heather E Dawson; Alessandro Lugli; Gieri Cathomas; Inti Zlobec
Journal:  Virchows Arch       Date:  2017-01-27       Impact factor: 4.064

Review 2.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

Review 3.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

Authors:  Alessandro Lugli; Richard Kirsch; Yoichi Ajioka; Fred Bosman; Gieri Cathomas; Heather Dawson; Hala El Zimaity; Jean-François Fléjou; Tine Plato Hansen; Arndt Hartmann; Sanjay Kakar; Cord Langner; Iris Nagtegaal; Giacomo Puppa; Robert Riddell; Ari Ristimäki; Kieran Sheahan; Thomas Smyrk; Kenichi Sugihara; Benoît Terris; Hideki Ueno; Michael Vieth; Inti Zlobec; Phil Quirke
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

4.  CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.

Authors:  A Lugli; E Karamitopoulou; I Panayiotides; P Karakitsos; G Rallis; G Peros; G Iezzi; G Spagnoli; M Bihl; L Terracciano; I Zlobec
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

5.  Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface.

Authors:  P Bronsert; K Enderle-Ammour; M Bader; S Timme; M Kuehs; A Csanadi; G Kayser; I Kohler; D Bausch; J Hoeppner; U T Hopt; T Keck; E Stickeler; B Passlick; O Schilling; C P Reiss; Y Vashist; T Brabletz; J Berger; J Lotz; J Olesch; M Werner; U F Wellner
Journal:  J Pathol       Date:  2014-11       Impact factor: 7.996

6.  TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.

Authors:  José A Galván; Melina Helbling; Viktor H Koelzer; Mario P Tschan; Martin D Berger; Marion Hädrich; Beat Schnüriger; Eva Karamitopoulou; Heather Dawson; Daniel Inderbitzin; Alessandro Lugli; Inti Zlobec
Journal:  Oncotarget       Date:  2015-01-20

Review 7.  Tumor Budding: The Name is EMT. Partial EMT.

Authors:  Alexandru Dan Grigore; Mohit Kumar Jolly; Dongya Jia; Mary C Farach-Carson; Herbert Levine
Journal:  J Clin Med       Date:  2016-04-29       Impact factor: 4.241

Review 8.  Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.

Authors:  A C Rogers; D C Winter; A Heeney; D Gibbons; A Lugli; G Puppa; K Sheahan
Journal:  Br J Cancer       Date:  2016-09-06       Impact factor: 7.640

9.  Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.

Authors:  Linde De Smedt; Sofie Palmans; Daan Andel; Olivier Govaere; Bram Boeckx; Dominiek Smeets; Eva Galle; Jasper Wouters; David Barras; Madeleine Suffiotti; Jeroen Dekervel; Thomas Tousseyn; Gert De Hertogh; Hans Prenen; Sabine Tejpar; Diether Lambrechts; Xavier Sagaert
Journal:  Br J Cancer       Date:  2016-11-24       Impact factor: 7.640

10.  MicroRNA-200b is downregulated in colon cancer budding cells.

Authors:  Kirsten Nguyen Knudsen; Jan Lindebjerg; Boye Schnack Nielsen; Torben Frøstrup Hansen; Flemming Brandt Sørensen
Journal:  PLoS One       Date:  2017-05-26       Impact factor: 3.240
  10 in total
  20 in total

1.  Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition.

Authors:  Valeria Maffeis; Rocco Cappellesso; Francesca Galuppini; Vincenza Guzzardo; Alessia Zanon; Diego Cazzador; Enzo Emanuelli; Laura Ventura; Alessandro Martini; Ambrogio Fassina
Journal:  Virchows Arch       Date:  2020-01-24       Impact factor: 4.064

2.  Spatial immune profiling of the colorectal tumor microenvironment predicts good outcome in stage II patients.

Authors:  Ines P Nearchou; Bethany M Gwyther; Elena C T Georgiakakis; Christos G Gavriel; Kate Lillard; Yoshiki Kajiwara; Hideki Ueno; David J Harrison; Peter D Caie
Journal:  NPJ Digit Med       Date:  2020-05-15

Review 3.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

4.  Continuous formation of small clusters with LGR5-positive cells contributes to tumor growth in a colorectal cancer xenograft model.

Authors:  Masaki Yamazaki; Atsuhiko Kato; Eiji Oki; Yoko Zaitsu; Chie Kato; Kiyotaka Nakano; Miho Nakamura; Takuya Sakomura; Shigeto Kawai; Etsuko Fujii; Noriaki Sawada; Takeshi Watanabe; Hiroshi Saeki; Masami Suzuki
Journal:  Lab Invest       Date:  2020-07-29       Impact factor: 5.662

5.  A Comparison of Methods for Studying the Tumor Microenvironment's Spatial Heterogeneity in Digital Pathology Specimens.

Authors:  Ines Panicou Nearchou; Daniel Alexander Soutar; Hideki Ueno; David James Harrison; Ognjen Arandjelovic; Peter David Caie
Journal:  J Pathol Inform       Date:  2021-01-28

6.  The battle for prognosis at the invasive front of colorectal cancer.

Authors:  Alessandro Lugli; Inti Zlobec
Journal:  EBioMedicine       Date:  2020-07-22       Impact factor: 8.143

Review 7.  Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?

Authors:  Annika Blank; Daniel Edward Roberts; Heather Dawson; Inti Zlobec; Alessandro Lugli
Journal:  Front Med (Lausanne)       Date:  2018-08-31

Review 8.  Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features.

Authors:  Eva Karamitopoulou
Journal:  Br J Cancer       Date:  2019-05-21       Impact factor: 7.640

Review 9.  The histomorphological and molecular landscape of colorectal adenomas and serrated lesions.

Authors:  Francesca Galuppini; Matteo Fassan; Luca Mastracci; Roberta Gafà; Marcello Lo Mele; Stefano Lazzi; Andrea Remo; Paola Parente; Alessandro D'Amuri; Claudia Mescoli; Fabiana Tatangelo; Giovanni Lanza
Journal:  Pathologica       Date:  2021-06

10.  Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer.

Authors:  Kenji Fujiyoshi; Juha P Väyrynen; Jennifer Borowsky; David J Papke; Kota Arima; Koichiro Haruki; Junko Kishikawa; Naohiko Akimoto; Tomotaka Ugai; Mai Chan Lau; Simeng Gu; Shanshan Shi; Melissa Zhao; Annacarolina Fabiana Lucia Da Silva; Tyler S Twombly; Hongmei Nan; Jeffrey A Meyerhardt; Mingyang Song; Xuehong Zhang; Kana Wu; Andrew T Chan; Charles S Fuchs; Jochen K Lennerz; Marios Giannakis; Jonathan A Nowak; Shuji Ogino
Journal:  EBioMedicine       Date:  2020-07-08       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.